Literature DB >> 14731838

Aetiology of seroma formation in patients undergoing surgery for breast cancer.

J A McCaul1, A Aslaam, R J Spooner, I Louden, T Cavanagh, A D Purushotham.   

Abstract

Surgery for primary breast cancer and regional nodes often involves the use of suction drains post-operatively. It is believed that the fluid accumulating following axillary surgery is lymph from divided lymphatics or alternatively serum, although the composition of this fluid has never been studied in detail. Drain fluid following surgery for primary breast cancer was analysed for a number of haematological and biochemical parameters. Comparison of these values with plasma concentration produced a ratio that was compared with established lymph to plasma ratios. Haematological analysis indicates minimal contamination with blood. Comparison of drain fluid to plasma ratios with known lymph to plasma values for biochemical parameters showed that this fluid is compositionally different from lymph, but is similar to inflammatory exudate. Altering surgical technique to close dead space may avert the need for wound drainage, lead to reduced hospital stay and reduce the incidence of 'seroma' formation.

Entities:  

Year:  2000        PMID: 14731838     DOI: 10.1054/brst.1999.0126

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  25 in total

1.  Porcine Dermal Collagen Prevents Seroma Formation After Mastectomy and Axillary Dissection in Rats.

Authors:  Cihan Ağalar; Ali İbrahim Sevinç; Anıl Aysal; Tufan Egeli; Özkan Süleyman Aksoy; Mehmet Ali Koçdor
Journal:  Eur J Breast Health       Date:  2017-10-01

2.  Postlymphadenectomy Analysis of Exosomes from Lymphatic Exudate/Exudative Seroma of Melanoma Patients.

Authors:  Susana García-Silva; Pilar Ximénez-Embún; Javier Muñoz; Héctor Peinado
Journal:  Methods Mol Biol       Date:  2021

3.  Factors that Affect Drain Indwelling Time after Breast Cancer Surgery.

Authors:  Ömer Uslukaya; Ahmet Türkoğlu; Metehan Gümüş; Zübeyir Bozdağ; Ahmet Yılmaz; Hatice Gümüş; Şeyhmus Kaya; Mesut Gül
Journal:  J Breast Health       Date:  2016-07-01

4.  Reducing postsurgical exudate in breast cancer patients by using San Huang decoction to ameliorate inflammatory status: a prospective clinical trial.

Authors:  Z Y Zhu; J X Xue; L X Yu; W H Bian; Y F Zhang; K C Sohn; I H Shin; C Yao
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

5.  Microporous polysaccharide hemospheres and seroma formation after mastectomy and axillary dissection in rats.

Authors:  Tufan Egeli; Ali İbrahim Sevinç; Seymen Bora; Mehmet Can Yakut; Tansu Cevizci; Tülay Canda; Ali Rıza Sişman
Journal:  Balkan Med J       Date:  2012-06-01       Impact factor: 2.021

Review 6.  Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and axillary surgery.

Authors:  Muhammad S Sajid; Kristian H Hutson; Ignazio F Rapisarda; Riccardo Bonomi
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31

7.  The Use of TissuGlu® Surgical Adhesive for Mastectomy With or Without Lymphonodectomy.

Authors:  Ralf Ohlinger; Leonie Gieron; Rico Rutkowski; Thomas Kohlmann; Marek Zygmunt; Julia Unger
Journal:  In Vivo       Date:  2018 May-Jun       Impact factor: 2.155

8.  Effects of local phenytoin on seroma formation after mastectomy and axillary lymph node dissection: an experimental study on mice.

Authors:  Mehmet Eser; Fırat Tutal; Metin Kement; Selcuk Goktas; Levent Kaptanoglu; Mehmet Gökceimam; Melin Ozgun Gecer; Huseyin Uzun
Journal:  BMC Surg       Date:  2012-12-19       Impact factor: 2.102

9.  Collagen sealant patch to reduce lymphatic drainage after lymph node dissection.

Authors:  Gianluca Di Monta; Corrado Caracò; Anna Crispo; Ugo Marone; Nicola Mozzillo
Journal:  World J Surg Oncol       Date:  2012-12-19       Impact factor: 2.754

10.  Analysis of selected factors influencing seroma formation in breast cancer patients undergoing mastectomy.

Authors:  Jacek Zieliński; Radosław Jaworski; Ninela Irga; Janusz Wiesław Kruszewski; Janusz Jaskiewicz
Journal:  Arch Med Sci       Date:  2012-06-28       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.